Correlation Study of Family Communication Disorders and Negative Network Use Behavior Among Adolescents

August 13, 2023 updated by: Wei XIA, PhD
The entry point of this project is the social background of the post-epidemic era, with teenagers and parents as the research object, aims to explore the relationship between family communication disorders and adolescent negative network use behavior in the post-epidemic era. This project intends to investigate whether there are family communication disorders and negative Internet use behaviors among 14-25 year old teenagers by issuing questionnaires (sample size: 140). In order to conclude whether there is some connection between family communication disorder and adolescent negative network use behavior.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

This research project takes the "post-epidemic era" as the background entry point, and explores the relationship between teenagers' negative Internet use behavior and family communication by using questionnaires. Through literature review, it is obtained that family communication disorders may be related to adolescents' emotional changes with their parents, limited peer interaction, and changes in the structure of their lives. In order to avoid the negative feelings brought by family communication barriers, adolescents tend to turn to other areas such as virtual networks to compensate and regain happiness, which can easily lead to negative Internet use behaviors if they are not careful. By studying the "loss of compensation" model proposed by Chinese scholar Gao Wenbin, the application of the "loss of compensation" model to family communication disorders and adolescents' negative Internet use behavior is derived. In this context, if we can study the correlation between family communication barriers and adolescents' negative Internet use behaviors, it will be beneficial to ease the parent-child relationship, correct adolescents' negative Internet use behaviors, and promote the healthy growth of adolescents.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
140

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • China
    • Guangdong
      • Guangzhou, Guangdong, China, 510080
        • Recruiting
        • Sun Yat-sen University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

General adolescents between 14-25 years old and their parents

Description

Inclusion Criteria:

  • Adolescents aged 14-25 (including 14,25 years old) and their parents;
  • Agree to participate in the studies

Exclusion Criteria:

  • Persons of interest with a history of prior psychiatric illness, who are suffering from a serious acute illness, are unconscious, emotionally unstable, and unable to communicate normally

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Investigation Team

Questionnaires assessed adolescents and their parents ①Adolescents aged 14-25 years old (including 14,25 years old) and their parents, who agreed to participate in the study

②Investigate whether they have family communication difficulties and whether they have negative internet use behaviors

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Parent-child communication skills
Time Frame: Baseline
Parent-Child Communication Skills Subscale with 20-item will be used to measure Parent-child communication skills. The scale uses Likert 4 comments, higher dimension scores indicate better communication ability.
Baseline
Parent-child communication quality
Time Frame: Baseline
The Parent-Child Communication Quality Subscale with 12 items will be used to measure the communication skills of fathers, mothers and children separately. The scale uses Likert 4 comments, higher dimension scores indicate higher quality of parent-child communication in terms of relationship enhancement or problem solving.
Baseline
Parent-child communication system subscales
Time Frame: Baseline
The Parent-Child Communication System Subscale with 18 items will be used to measure the relationship between father-child communication and mother-child communication. The scale uses Likert 4 comments, the larger the difference, the greater the difference in parental roles and the greater the imbalance in communication status.
Baseline
Social support received by adolescents
Time Frame: Baseline
The 17-item Adolescent Social Support Scale will be used to measure the support received by adolescents in society. The scale uses 5-point scale, higher scores indicate better social support.
Baseline
Peer communication
Time Frame: Baseline
A 24-item Peer Attachment Scale will be used to measure adolescents' communication with their peers. The scale uses 5-point scale, higher scores indicate higher quality of peer attachment.
Baseline
Internet addiction among adolescents
Time Frame: Baseline
The 26-item Chinese Internet Addiction Scale will be used to measure the situation of Internet addiction among adolescents. The scale uses Likert 4 comments, higher scores indicate a higher propensity for Internet addiction.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Wei XIA, PhD

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Wei Xia, PhD, Sun Yat-sen University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
July 1, 2023

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
October 31, 2023

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
November 30, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
July 3, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 3, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
July 11, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 15, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 13, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 202310892

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings